{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:51:16Z","timestamp":1790193076784,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jchf.2017.04.008","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T01:12:02Z","timestamp":1500426722000},"page":"632-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical Effectiveness of Hydralazine\u2013Isosorbide Dinitrate in African-American Patients With Heart\u00a0Failure"],"prefix":"10.1016","volume":"5","author":[{"given":"Boback","family":"Ziaeian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2017.04.008_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.008_bib2","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/CIRCULATIONAHA.110.012781","article-title":"Hydralazine and isosorbide dinitrate in heart\u00a0failure: historical perspective, mechanisms, and future directions","volume":"123","author":"Cole","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.008_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group","volume":"5","author":"Carson","year":"1999","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2017.04.008_bib4","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","article-title":"2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the management of heart failure","volume":"68","author":"Yancy","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.008_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.008_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC)","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2017.04.008_bib7","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.008_bib8","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.008_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1748-720X.2008.290.x","article-title":"Flaws in the U.S. Food and Drug Administration\u2019s rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients","volume":"36","author":"Ellison","year":"2008","journal-title":"J\u00a0Law Med Ethics"},{"key":"10.1016\/j.jchf.2017.04.008_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjcard.2009.08.681","article-title":"Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF)","volume":"105","author":"Yancy","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2017.04.008_bib11","doi-asserted-by":"crossref","first-page":"e000214","DOI":"10.1161\/JAHA.113.000214","article-title":"Use of hydralazine-isosorbide dinitrate combination in African American and other race\/ethnic group patients with heart failure and reduced left ventricular ejection fraction","volume":"2","author":"Golwala","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2017.04.008_bib12","doi-asserted-by":"crossref","first-page":"e002444","DOI":"10.1161\/CIRCHEARTFAILURE.115.002444","article-title":"Clinical effectiveness of hydralazine-isosorbide dinitrate therapy in patients with heart failure and reduced ejection fraction: findings from the Get With The Guidelines-Heart Failure Registry","volume":"9","author":"Khazanie","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2017.04.008_bib13","unstructured":"Veterans Health Administration. Available at: http:\/\/www.va.gov\/health\/. Accessed January 1,\u00a02016."},{"key":"10.1016\/j.jchf.2017.04.008_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1748-5908-7-45","article-title":"Improving quality of care through improved audit and feedback","volume":"7","author":"Hysong","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.jchf.2017.04.008_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","article-title":"Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry","volume":"53","author":"Hernandez","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.04.008_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.jchf.2017.04.008_bib17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.04.008_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.amjcard.2012.06.038","article-title":"Predicting risk of hospitalization or death among patients with heart failure in the Veterans Health Administration","volume":"110","author":"Wang","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2017.04.008_bib19","doi-asserted-by":"crossref","unstructured":"Austin PC, Stuart EA. The performance of inverse probability of treatment weighting and full\u00a0matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes. Stat\u00a0Methods Med\u00a0Res 2015 Apr 30 [E-pub ahead of print].","DOI":"10.1177\/0962280215584401"},{"key":"10.1016\/j.jchf.2017.04.008_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.04.008_bib21","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.008_bib22","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1161\/CIRCULATIONAHA.105.563882","article-title":"Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure","volume":"112","author":"Angus","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.04.008_bib23","first-page":"419","article-title":"Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis","volume":"7","author":"Srivastava","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jchf.2017.04.008_bib24","doi-asserted-by":"crossref","first-page":"e001134","DOI":"10.1161\/JAHA.114.001134","article-title":"Short- and long-term rehospitalization and mortality for heart failure in 4 racial\/ethnic populations","volume":"3","author":"Vivo","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2017.04.008_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.04.008_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2011.06.007","article-title":"Medication adherence: a call for action","volume":"162","author":"Bosworth","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2017.04.008_bib27","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917302780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917302780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T04:09:06Z","timestamp":1659240546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177917302780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213177917302780"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2017.04.008","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Effectiveness of Hydralazine\u2013Isosorbide Dinitrate in African-American Patients With Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2017.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the","name":"copyright","label":"Copyright"}]}}